Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Pine Grove launches Alternative Institutional Fund

Thursday, January 23, 2014

Bailey McCann, Opalesque New York:

Pine Grove Asset Management LLC (PGAM) has launched the Pine Grove Alternative Institutional Fund, the fund is its first closed-end '40 act fund. The new offering will provide accredited investors with streamlined access to relative value and event driven hedge fund strategies with a core focus on credit investing. The launch is a notable addition to the '40 act space as unlike many others, the fund offers quarterly liquidity and an undiluted strategy.

In bringing the new product to market, PGAM took deliberate steps to convert a private, unregistered fund into a registered '40 Act fund format. The original, private fund was incepted in the 1990s and only available to qualified purchasers.

"We are investing in the same underlying managers and the same flagship funds as we did for the private fund. Open-ended funds in this space, are most likely allocating to separate accounts to offer daily liquidity. Keeping our investments the same allows us to continue to provide the appropriate assets and liabilities match, and also accounts for our quarterly liquidity profile," says Matthew Stadtmauer, PGAM President, in an interview with Opalesque.

The new product will benefit from the 16-year history of the underlying managers and funds from the private fund. The fund invests in hedge funds that employ a variety of investment strategies, including distressed credit investing, hedged credit, convertible arbitrage and long/short ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its